As of April 16, 2025, Belite Bio (BLTE) has a market cap of $1.90 billion USD. According to our data, Belite Bio is ranked No.4056 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.90 B |
-5.39%
|
Dec 31, 2024 | $2.01 B |
37.92%
|
Dec 29, 2023 | $1.46 B |
51.77%
|
Dec 30, 2022 | $0.96 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Apellis Pharmaceuticals
APLS
|
$2.38 B |
-0.000 M
|
![]() USA
|
![]() Kodiak Sciences
KOD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() ProQR
PRQR
|
$0.13 B |
0.000 M
|
![]() Netherlands
|
![]() MeiraGTx
MGTX
|
$0.43 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
Market Cap | = | BLTE Stock Price | * | BLTE Shares Outstanding |
= | $58.88 | * | 32.28 M | |
= | $1.90 B |